{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:46:26Z","timestamp":1786988786211,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.eprac.2023.12.014","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T12:21:32Z","timestamp":1703852492000},"page":"282-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-2728","authenticated-orcid":false,"given":"Kevin C.J.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luma","family":"Ghalib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Molitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2023.12.014_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinimag.2021.11.004","article-title":"Evolution of postoperative pituitary adenoma resection cavities assessed by magnetic resonance imaging and implications regarding radiotherapy timing and modality","volume":"82","author":"Farnworth","year":"2021","journal-title":"Clin Imaging"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an Endocrine Society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2023.12.014_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4158\/EP14541.DSCR","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: postoperative management following pituitary surgery","volume":"21","author":"Woodmansee","year":"2015","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib4","doi-asserted-by":"crossref","first-page":"E541","DOI":"10.1227\/NEU.0000000000001392","article-title":"Congress of Neurological Surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas","volume":"79","author":"Ziu","year":"2016","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ando.2015.04.003","article-title":"Post-surgical management of non-functioning pituitary adenoma","volume":"76","author":"Cortet-Rudelli","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"7","key":"10.1016\/j.eprac.2023.12.014_bib6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jacr.2018.03.037","article-title":"Management of incidental pituitary findings on CT, MRI, and 18F-fluorodeoxyglucose PET: a White Paper of the ACR Incidental Findings Committee","volume":"15","author":"Hoang","year":"2018","journal-title":"J\u00a0Am Coll Radiol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib7","first-page":"761","article-title":"Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery","volume":"134","author":"Alhilali","year":"2020","journal-title":"J\u00a0Neurosurg"},{"issue":"27","key":"10.1016\/j.eprac.2023.12.014_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016089","article-title":"Differentiation of postoperative changes and residual tumors in dynamic contrast-enhanced sella MRI after transsphenoidal resection of pituitary adenoma","volume":"98","author":"Kim","year":"2019","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00701-013-1834-6","article-title":"The value of immediate postoperative MR imaging following endoscopic endonasal pituitary surgery","volume":"156","author":"Stofko","year":"2014","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ando.2015.04.005","article-title":"Biological and radiological exploration and management of non-functioning pituitary adenoma","volume":"76","author":"Raverot","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib13","first-page":"64","article-title":"Assessment of the extent of pituitary macroadenomas resection in immediate postoperative MRI","volume":"60","author":"Taberner Lopez","year":"2018","journal-title":"Radiol (Engl Ed)"},{"issue":"9","key":"10.1016\/j.eprac.2023.12.014_bib14","first-page":"744","article-title":"Recommendations for the diagnosis and radiological follow-up of pituitary neuroendocrine tumours","volume":"69","author":"Fajardo-Montanana","year":"2022","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11102-022-01289-x","article-title":"Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review","volume":"26","author":"Caulley","year":"2023","journal-title":"Pituitary"},{"issue":"Suppl","key":"10.1016\/j.eprac.2023.12.014_bib16","first-page":"563","article-title":"Neuroendocrine imaging. American College of Radiology. ACR Appropriateness Criteria","volume":"215","author":"Seidenwurm","year":"2000","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib17","first-page":"803","article-title":"Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification","volume":"122","author":"Micko","year":"2015","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.eprac.2023.12.014_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep35181","article-title":"Cumulative radiation exposure from imaging procedures and associated lifetime cancer risk for patients with lymphoma","volume":"6","author":"Fabritius","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib20","article-title":"Gadolinium-based contrast agents: updates and answers to typical questions regarding gadolinium use","volume":"49","author":"Cheong","year":"2022","journal-title":"Tex Heart Inst J"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.014_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/RLI.0000000000000072","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"49","author":"Errante","year":"2014","journal-title":"Invest Radiol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","author":"McDonald","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ejendo\/lvad070","article-title":"Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium","volume":"189","author":"Hamblin","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.014_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","article-title":"What is the natural history of nonoperated nonfunctioning pituitary adenomas?","volume":"67","author":"Karavitaki","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00004728-199207000-00004","article-title":"Volume of pituitary macroadenomas: assessment by MRI","volume":"16","author":"Lundin","year":"1992","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/EJE-07-0502","article-title":"Growth modelling of non-functioning pituitary adenomas in patients referred for surgery","volume":"158","author":"Honegger","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2023.12.014_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/a-2096-1340","article-title":"Natural history of non-functioning pituitary adenomas: a systematic review and meta-analysis","volume":"55","author":"Rikvold","year":"2023","journal-title":"Horm Metab Res"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.014_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11102-015-0652-7","article-title":"Pituitary incidentalomas: analysis of a neuroradiological cohort","volume":"18","author":"Esteves","year":"2015","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2010-1054","article-title":"Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis","volume":"96","author":"Fernandez-Balsells","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2023.12.014_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1055\/s-0043-115645","article-title":"Prevalence, clinical features, and natural history of incidental clinically non-functioning pituitary adenomas","volume":"49","author":"Iglesias","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.eprac.2023.12.014_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-444-59602-4.00012-5","article-title":"Nonfunctioning pituitary tumors","volume":"124","author":"Molitch","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib35","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1210\/clinem\/dgab748","article-title":"Nonfunctioning pituitary microadenomas: should imaging interval be extended? A large single-center cohort study","volume":"107","author":"Han","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ando.2015.04.002","article-title":"Management of clinically non-functioning pituitary adenoma","volume":"76","author":"Chanson","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.eprac.2023.12.014_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fendo.2018.00469","article-title":"Dopamine agonists for pituitary adenomas","volume":"9","author":"Cooper","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib38","doi-asserted-by":"crossref","first-page":"D11","DOI":"10.1530\/EJE-21-0344","article-title":"Cabergoline should be attempted in progressing non-functioning pituitary macroadenoma","volume":"185","author":"Greenman","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.014_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-10-0255","article-title":"Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients","volume":"163","author":"Brochier","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib41","first-page":"525","article-title":"Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence","volume":"108","author":"Losa","year":"2008","journal-title":"J\u00a0Neurosurg"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.014_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/eje.0.1440569","article-title":"Radiotherapy for non-functioning pituitary adenomas","volume":"144","author":"Boelaert","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.014_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/B:PITU.0000004801.95086.e2","article-title":"Radiotherapy for non-functioning pituitary tumors--when and under what circumstances?","volume":"6","author":"Gittoes","year":"2003","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.eprac.2023.12.014_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-11-0566","article-title":"Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?","volume":"165","author":"Reddy","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2023.12.014_bib45","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00701-018-3491-2","article-title":"Post-operative imaging assessment of non-functioning pituitary adenomas","volume":"160","author":"Patel","year":"2018","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.014_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-07-0099","article-title":"Relevance of Ki-67 and prognostic factors for recurrence\/progression of gonadotropic adenomas after first surgery","volume":"157","author":"Dubois","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.014_bib47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2265.2003.01784.x","article-title":"Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth","volume":"58","author":"Greenman","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.014_bib48","first-page":"359","article-title":"Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index","volume":"98","author":"Tanaka","year":"2003","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-009-9901-9","article-title":"Radiologic follow-up of non-functioning pituitary adenomas: rationale and cost effectiveness","volume":"93","author":"Coulter","year":"2009","journal-title":"J\u00a0Neurooncol"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","article-title":"The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas","volume":"26","author":"Nishioka","year":"2015","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A\u00a0new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A\u00a0Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.eprac.2023.12.014_bib53","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an Endocrine Society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2023.12.014_bib54","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2023.12.014_bib55","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2023.12.014_bib56","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s40618-019-01066-x","article-title":"A\u00a02019 update on TSH-secreting pituitary adenomas","volume":"42","author":"Beck-Peccoz","year":"2019","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib57","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11102-021-01205-9","article-title":"Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature","volume":"25","author":"Wang","year":"2022","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.014_bib58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12020-020-02432-z","article-title":"Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment","volume":"70","author":"Braun","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.eprac.2023.12.014_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11102-020-01094-4","article-title":"Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly","volume":"24","author":"Freda","year":"2021","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11102-009-0169-z","article-title":"Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review","volume":"13","author":"Mazziotti","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.eprac.2023.12.014_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.935759","article-title":"Pasireotide-induced shrinkage in GH and ACTH secreting pituitary adenoma: a systematic review and meta-analysis","volume":"13","author":"Mondin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-19-0681","article-title":"Is MRI follow-up relevant in patients with GH-secreting pituitary adenomas primarily treated and responsive to long-acting somatostatin analogues (SMSa)?","volume":"182","author":"Grandgeorge","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2023.12.014_bib63","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/cen.14539","article-title":"MRI follow-up of patients with acromegaly being treated with first-generation somatostatin receptor ligands after surgery","volume":"97","author":"Grandgeorge","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11102-017-0788-8","article-title":"T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective","volume":"20","author":"Potorac","year":"2017","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.014_bib65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s11102-020-01075-7","article-title":"Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly","volume":"23","author":"Varlamov","year":"2020","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib66","first-page":"798","article-title":"Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly","volume":"122","author":"Schwyzer","year":"2015","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib67","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1210\/jc.2007-2104","article-title":"Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly","volume":"93","author":"Alexopoulou","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2023.12.014_bib68","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1210\/jc.2003-032141","article-title":"Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery","volume":"89","author":"Zirkzee","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-21-0239","article-title":"More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY","volume":"185","author":"Fleseriu","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2023.12.014_bib70","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1210\/jc.2014-1843","article-title":"Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone","volume":"99","author":"Fleseriu","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2023.12.014_bib71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-22-0317","article-title":"Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension","volume":"187","author":"Fleseriu","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib72","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-20-1088","article-title":"Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations","volume":"184","author":"Reincke","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.014_bib73","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.wneu.2014.03.031","article-title":"Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence","volume":"82","author":"Kirkman","year":"2014","journal-title":"World Neurosurg"},{"issue":"12","key":"10.1016\/j.eprac.2023.12.014_bib74","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2023.12.014_bib75","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-21-0293","article-title":"Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study","volume":"185","author":"Baussart","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib76","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis","volume":"105","author":"Zamanipoor Najafabadi","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1530\/EJE-16-0897","article-title":"MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment","volume":"176","author":"Eroukhmanoff","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12020-017-1444-9","article-title":"Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis","volume":"59","author":"Xia","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of dopamine agonist-resistant prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.eprac.2023.12.014_bib80","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11102-019-01001-6","article-title":"Magnetic resonance imaging in the management of prolactinomas; a review of the evidence","volume":"23","author":"Varlamov","year":"2020","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib81","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ecl.2019.05.004","article-title":"Pituitary tumors in pregnancy","volume":"48","author":"Huang","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.eprac.2023.12.014_bib82","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/EJE-22-0180","article-title":"The importance of MRI quality and reader's experience for detecting an adenoma in Cushing's disease","volume":"187","author":"Nasi-Kordhishti","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2023.12.014_bib83","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1210\/jc.2018-00688","article-title":"Clinical and pathological aspects of silent pituitary adenomas","volume":"104","author":"Drummond","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23007942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23007942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:16:04Z","timestamp":1761516964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23007942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1530891X23007942"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.12.014","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}